MGC Pharma’s CogniCann results offer hope for dementia patients and their carers by Martin Lane June 7, 2022June 7, 2022 MGC Pharmaceuticals’ phase II clinical trial of its CogniCann THC/CBD oral spray has shown the drug […]
